ST3GAL1 and renal carcinoma: Previous studies revealed that ST3GAL1 may account for sialylation of EGFR in renal cancer cells, while ST3GAL6 may promote sialylation of EGFR in HeLa cells (Gong et al., 2020; Qi et al., 2020).